Pinatuzumab Biosimilar: Advancing CD22-Targeted Therapy in B-Cell Malignancies Pinatuzumab vedotin is an antibody-drug conjugate (ADC) targeting CD22, a cell surface … read more 12th Dec 2024 Shanza Riaz
Belantamab Biosimilar: Targeting BCMA for Multiple Myeloma Treatment Belantamab mafodotin is an antibody-drug conjugate (ADC) targeting B-cell maturation a … read more 12th Dec 2024 Shanza Riaz
Vibostolimab Biosimilar: Advancing Immune Activation with TIGIT Inhibition Vibostolimab is a monoclonal antibody that targets TIGIT (T-cell immunoglobulin and IT … read more 12th Dec 2024 Shanza Riaz
